Entera Bio Ltd. ENTX on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0001638097
0001638097
EIN:
LEI:
(CF Office: 03 Life Sciences)
Business address:
KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
Phone: 972-2-532-7151
KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
Phone: 972-2-532-7151
Mailing address:
KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
Category:
Non-accelerated filer
Smaller reporting company
Non-accelerated filer
Smaller reporting company
Filings:
323 EDGAR filings since May 1, 2015
323 EDGAR filings since May 1, 2015
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- March 28, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- March 28, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
- March 17, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 1.01 - Entry into a Material Definitive Agreement
- 3.02 - Unregistered Sales of Equity Securities
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
- January 10, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 9.01 - Financial Statements and Exhibits
- January 10, 2025 - 424B5: Prospectus [Rule 424(b)(5)] Open documentClick to Open document FilingOpen filingClick to Open filing
Selected Filings
[+] 8-K (current reports)
- March 28, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
- March 17, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 1.01 - Entry into a Material Definitive Agreement
- 3.02 - Unregistered Sales of Equity Securities
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
- January 10, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 9.01 - Financial Statements and Exhibits
- December 20, 2024 - 8-K/A: Current report - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- 5.07 - Submission of Matters to a Vote of Security Holders
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- March 28, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- November 8, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 9, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 10, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- June 20, 2024 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
- May 29, 2024 - PRE 14A: Other preliminary proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- January 17, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- January 17, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- January 17, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- January 6, 2025 - SCHEDULE 13G: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- November 20, 2024 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- August 20, 2024 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 12 of 323 entries
Data source:
CIK0001638097.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
